Monitor this situation.
Unsubscribe anytime.
[SITUATION] · [QUIET] · [BUSINESS]
2 clusters · 4 sources · 19 days · First seen · Last updated
LG Chem strategic industry partnerships
Overview
LG Chem is pursuing diverse strategic partnerships across multiple industries to expand its global capabilities.
In the pharmaceutical sector, the company is utilizing an “open innovation” strategy to advance drug development. This approach involves leveraging external artificial intelligence for early-stage candidate discovery, as well as engaging in joint research, technology licensing, and mergers and acquisitions. Notable collaborations include working with LabGenius Therapeutics on tumor-targeted antibodies, partnering with Galux on AI-based protein design for cancer research, and licensing an obesity treatment candidate to Rhythm Pharmaceuticals.
In the automotive sector, LG Chem has entered a Memorandum of Understanding with Volkswagen Group to develop eco-friendly mobility materials. The partnership focuses on using high-performance synthetic resins, such as Acrylonitrile Butadiene Styrene and Engineering Plastics, to improve vehicle performance and lightweighting. The companies also intend to explore the application of recycled materials and circular economy solutions across Volkswagen’s vehicle brands.
Entities
LG Chem · LG Uplus · LabGenius Therapeutics · Stefan Gramze · Volkswagen Group
Timeline
-
[BUSINESS] 3 sourcesLG Chem and Volkswagen Group partner on eco-friendly mobility materials
LG Chem and Volkswagen Group have partnered to develop next-generation, eco-friendly mobility materials, focusing on high-performance plastics and recycled resins for automotive applications.
-
[BUSINESS] 2 sourcesLG Chem expands global drug development via open innovation
LG Chem is broadening its global drug development footprint by integrating AI-driven research, technology licensing, and M&A to accelerate new drug discovery and commercialization.
Sources
biz.heraldcorp.com · energy-news.co.kr · thebionews.net · zdnet.co.kr